Around 10.000 employees are working all around the globe, in production plants in 14 countries. One Gerresheimer team. Welcome to Gerresheimer. Our passion: Innovating for a better life. gerresheimer.com/en/careers #innovatingforabetterlife #Career

The leading supplier of injection vials Gerresheimer expands production in Wertheim gerresheimer.com/en/company/new… #innovatingforabetterlife #pharma #germany #production

Gerresheimer accelerates growth and raises mid term guidance gerresheimer.com/en/company/new… #innovatingforabetterlife #healthcare #cosmetics #biologics

Our fiscal year 2021 at a glance Our video summarizes the key results and statements on fiscal 2021! Click here for our annual report: gerresheimer.com/en/company/inv… #innovatingforabetterlife #gerresheimer# #pharma #cosmetics #biologicals

As a supplier of critical healthcare infrastructure, we are an essential and mission-critical partner for everyone needing these products – in particular Pharma and biotech companies. Our annual report 2021: gerresheimer.com/en/company/inv…

Sustainable entrepreneurship and profitable growth are not mutually exclusive, but rather mutually dependent. We have driven the transformation of our Gerresheimer into a sustainable and innovative growth company. gerresheimer.com/en/company/inv… #innovatingforabetterlife #sustainability

Gerresheimer raises revenue guidance for 2022 to double-digit growth after strong first quarter gerresheimer.com/en/company/new… #gerresheimer #innovatingforabetterlife

Annual General Meeting of Gerresheimer AG approves dividend of EUR 1.25 per share following a successful financial year – Gradual renewal of Supervisory Board initiated gerresheimer.com/en/company/new…

Gerresheimer has assumed responsibility for the industrialization of a dry powder inhaler for the treatment of respiratory ailments for Merxin (United Kingdom), a company that specializes in making inhaler devices. gerresheimer.com/en/company/new…

On more than 100 square meters we will showcase our developments. The wide range of products includes solutions, products and delivery systems for drugs, vaccines or high potency biologics. Come to our booth, check out our products and talk to our experts. #cphi #pharma

Gerresheimer continues dynamic growth in first half of 2023 Read our Corporate News lnkd.in/erq7gJXu #innovatingforabetterlife #gerresheimer #pharma

The German financial magazine „Der Aktionär“ published an article about Gerresheimer in its issue No. 35/2023. The interview (in German, paywall) can also be found here: deraktionaer.de/artikel/pharma… #gerresheimer #pharma #bitotech #press

Gerresheimer awarded EcoVadis Gold status again As an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, we have once again been awarded Gold status by the ratings agency EcoVadis. gerresheimer.com/en/company/new…

Press release: Green electricity from wind for German production sites gerresheimer.com/en/company/new… #Sustainability #greenelectricity

Gerresheimer decisively continued on its profitable growth course in the financial year 2023.​ Read our Corporate News: gerresheimer.com/en/company/new… #FYresults #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery

“In 2023, we achieved double-digit revenue and adjusted EBITDA growth. We expanded our organic adjusted EBITDA margin by 120 basis points 20.8%.”​ ​ Read our annual report: ​gerresheimer.com/fileadmin/user… #FYresults #gerresheimer #pharma #cosmetics #drugdelivery

We will publish our Q1 2024 results on April 11, 2024 at 7 am CEST on our website in the IR section here: gerresheimer.com/en/company/inv…

Gerresheimer reports a solid start to the financial year 2024 and continues its profitable growth course. gerresheimer.com/en/company/new… #FYresults #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery

Gerresheimer builds new production capacities for glass syringes at Skopje site gerresheimer.com/en/company/new…

Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group gerresheimer.com/en/company/new… #pharmamanufacturing #drugdelivery #drugdevices #biotech